Disaggregation of Alzheimer beta-amyloid by site-directed mAb.
about
Clinical immunologic approaches for the treatment of Alzheimer's diseaseImmunotherapy as treatment for Alzheimer’s diseaseNasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer diseaseActive and passive immunotherapy for neurodegenerative disordersThe immunotherapy of Alzheimer's diseaseImmunotherapy for Alzheimer's disease: hoops and hurdlesTau-targeted treatment strategies in Alzheimer's diseaseCD4 T cells in immunity and immunotherapy of Alzheimer's diseaseMolecular basis for passive immunotherapy of Alzheimer's diseaseStabilization of a -hairpin in monomeric Alzheimer's amyloid- peptide inhibits amyloid formationStructures of Aβ-Related Peptide−Monoclonal Antibody Complexes ,Immunotherapeutic approaches for Alzheimer's diseaseDisease modifying therapies for Alzheimer's disease targeting Aβ oligomers: implications for therapeutic mechanismsAn anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 miceStimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease.Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse modelDirected selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils.Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds.Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's diseaseClinical applications of a peptide-based vaccine for glioblastoma.Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.EGFRvIII-targeted vaccination therapy of malignant glioma.Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimer's diseaseAlzheimer's disease: is a vaccine possible?Amyloid-beta immunotherapy for Alzheimer's diseaseConformational Abs recognizing a generic amyloid fibril epitope.Beta-amyloid therapies in Alzheimer's disease.A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease.Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 miceHyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.Novel immunological approaches for the treatment of Alzheimer's disease.Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease.Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.Immunotherapy for Alzheimer's disease.Investigating interventions in Alzheimer's disease with computer simulation modelsImmunological approaches as therapy for Alzheimer's disease.
P2860
Q22241380-63D332B0-461E-40A8-9544-311890FFF075Q22241491-BA6FA6D3-26DB-4368-8BC2-97954D2D9584Q24534813-BCD7EC3C-3BE5-433E-9CC6-0AC4BF602D0BQ24657879-0DCB5EC6-E894-430B-82EC-B9C26A9EC019Q24804900-E6810F85-4E4B-4F83-A0C7-8E73AFEA0EB3Q26823877-D72EF84A-9FED-4739-94AE-DF660B8781C1Q27023429-3B16A5FC-9247-44CA-9D9F-A34EC2BA0D30Q27024202-BEBC1EE9-5FD2-4EA2-97A4-076DC95A22C7Q27648521-6F04C59E-9A56-4BD4-90D2-23A2698A468CQ27650192-F88B9288-E7CE-4A7F-951F-1D67C44D7207Q27655072-17865FBC-ED24-444C-98E3-93877DA5207AQ28081278-5420DC6D-4FE7-4AF1-9188-A75305633B3BQ28680809-5DB18F5E-0B79-41F5-B72E-ACE0B962C0CFQ30316057-A3993B83-4697-44CA-B61C-3B5883356A3AQ30478932-37EC7D7D-2E16-44D7-A210-DD52F0853C09Q31151076-62223A4D-569A-4165-9F74-A2E5CA4E2191Q33240688-CF938B57-27D3-43CF-AF6A-BF207B091F5EQ33307478-7C54D704-5AC3-4807-BD31-5419B52E9B49Q33381465-4FC3F51A-B22D-4035-8E2D-D29D0FE2E4DFQ33392254-7FB20E3A-DF03-4BE5-92AF-E39CACA70136Q33624303-D4066375-9DDF-408B-A103-1BEC26E0E176Q33668575-76ED745D-1F97-4B62-B6B4-3C82C6FE56CAQ33742312-25BF6EF4-782C-4D77-9F23-1F86092E8D3AQ33758459-D2A38696-F354-41BC-95BB-5C7479010FF7Q33773936-867838C4-D7CB-4043-9FDC-B3E138410314Q33861011-907C94BA-547C-4D0A-9B39-715BC01D2387Q33954737-8122358D-A156-490D-892A-77C5F8C30808Q34009881-39FF0D4D-7C41-4338-9925-5C7E5EAC4642Q34204313-3F297E21-3C81-40A6-9245-B6D8AF5382CFQ34376103-DB83CA0F-133E-43BE-8FFC-6DD29AB17454Q34506405-1B6D4032-EA04-4F5A-8D9D-5FA7BC72D647Q34553059-301A7733-E7D9-45C3-9F26-0DF7F17D444CQ34562675-C91BDB44-DA72-4282-B4A6-827CBB000209Q34574825-2309BFEB-1F96-4BC8-AB55-010C30D8EBE4Q34698382-E286B6BB-DD38-4A51-99B9-6F328EE2334FQ34721350-F66C9151-1C95-40D3-A3A3-6801E5A01B01Q34763076-71E2EB5C-3A41-4B12-BECB-CC76F2320509Q34783722-6335CDCF-478F-405C-A6BD-D66F34299669Q35009820-4652B10D-A0C5-4082-BC6B-030EC2BDFA50Q35040852-E1E8C8EF-66A3-45A8-B2A6-6EA9590C77CF
P2860
Disaggregation of Alzheimer beta-amyloid by site-directed mAb.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Disaggregation of Alzheimer beta-amyloid by site-directed mAb.
@ast
Disaggregation of Alzheimer beta-amyloid by site-directed mAb.
@en
type
label
Disaggregation of Alzheimer beta-amyloid by site-directed mAb.
@ast
Disaggregation of Alzheimer beta-amyloid by site-directed mAb.
@en
prefLabel
Disaggregation of Alzheimer beta-amyloid by site-directed mAb.
@ast
Disaggregation of Alzheimer beta-amyloid by site-directed mAb.
@en
P2093
P2860
P356
P1476
Disaggregation of Alzheimer beta-amyloid by site-directed mAb.
@en
P2093
E Hanan-Aharon
P2860
P304
P356
10.1073/PNAS.94.8.4109
P407
P577
1997-04-01T00:00:00Z